A deeptech biotech developing a DNA sequence design platform to overcome cellular silencing that limits genetic medicines.
| Date | Round | Amount |
|---|---|---|
| Jun 2026 | Pre Seed Houdini Bio emerged from stealth with roughly 1.5 million pounds in pre-seed funding to validate its DNA sequence design infrastructure for gene therapies. | $1.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.